11-2160955-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_000207.3(INS):c.17G>A(p.Arg6His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000986 in 1,612,270 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain risk allele (★★).
Frequency
Genomes: 𝑓 0.00018 ( 0 hom., cov: 35)
Exomes 𝑓: 0.000090 ( 0 hom. )
Consequence
INS
NM_000207.3 missense
NM_000207.3 missense
Scores
2
3
13
Clinical Significance
Conservation
PhyloP100: 0.142
Genes affected
INS (HGNC:6081): (insulin) This gene encodes insulin, a peptide hormone that plays a vital role in the regulation of carbohydrate and lipid metabolism. After removal of the precursor signal peptide, proinsulin is post-translationally cleaved into three peptides: the B chain and A chain peptides, which are covalently linked via two disulfide bonds to form insulin, and C-peptide. Binding of insulin to the insulin receptor (INSR) stimulates glucose uptake. A multitude of mutant alleles with phenotypic effects have been identified, including insulin-dependent diabetes mellitus, permanent neonatal diabetes diabetes mellitus, maturity-onset diabetes of the young type 10 and hyperproinsulinemia. There is a read-through gene, INS-IGF2, which overlaps with this gene at the 5' region and with the IGF2 gene at the 3' region. [provided by RefSeq, May 2020]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.17572835).
BS2
High AC in GnomAd4 at 28 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
INS | NM_000207.3 | c.17G>A | p.Arg6His | missense_variant | 2/3 | ENST00000381330.5 | NP_000198.1 | |
INS-IGF2 | NR_003512.4 | n.76G>A | non_coding_transcript_exon_variant | 2/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
INS | ENST00000381330.5 | c.17G>A | p.Arg6His | missense_variant | 2/3 | 1 | NM_000207.3 | ENSP00000370731 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152184Hom.: 0 Cov.: 35
GnomAD3 genomes
AF:
AC:
28
AN:
152184
Hom.:
Cov.:
35
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000933 AC: 23AN: 246470Hom.: 0 AF XY: 0.0000895 AC XY: 12AN XY: 134134
GnomAD3 exomes
AF:
AC:
23
AN:
246470
Hom.:
AF XY:
AC XY:
12
AN XY:
134134
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000897 AC: 131AN: 1460086Hom.: 0 Cov.: 88 AF XY: 0.0000977 AC XY: 71AN XY: 726374
GnomAD4 exome
AF:
AC:
131
AN:
1460086
Hom.:
Cov.:
88
AF XY:
AC XY:
71
AN XY:
726374
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000184 AC: 28AN: 152184Hom.: 0 Cov.: 35 AF XY: 0.000148 AC XY: 11AN XY: 74350
GnomAD4 genome
AF:
AC:
28
AN:
152184
Hom.:
Cov.:
35
AF XY:
AC XY:
11
AN XY:
74350
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
8
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance/Uncertain risk allele
Submissions summary: Uncertain:2Other:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Maturity-onset diabetes of the young type 10 Other:2
not provided, no classification provided | literature only | UniProtKB/Swiss-Prot | - | - - |
Uncertain risk allele, criteria provided, single submitter | research | Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic | - | Potent mutations in the INS gene can cause early onset diabetes mellitus which is insulin dependent. May have poor response to sulfonylureas, mutations in this gene can cause beta cell destruction.Sufficient evidence is found to confer the association of this particular R6H/rs121908259 with Maturity-onset diabetes of the young (MODY). - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 05, 2024 | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 6 of the INS protein (p.Arg6His). This variant is present in population databases (rs121908259, gnomAD 0.03%). This missense change has been observed in individual(s) with autosomal dominant maturity onset diabetes of the young (MODY) or type 2 diabetes (PMID: 20007936, 24097065, 29758564). ClinVar contains an entry for this variant (Variation ID: 68727). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Not Available"; Align-GVGD: "Not Available". The histidine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. Experimental studies have shown that this missense change affects INS function (PMID: 20007936, 24770419). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
INS-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Apr 12, 2023 | The INS c.17G>A variant is predicted to result in the amino acid substitution p.Arg6His. This variant has been reported in individuals with Maturity Onset Diabetes of the Young (MODY) (Meur et al 2010. PubMed ID: 20007936; de Santana et al. 2019. PubMed ID: 31595705). In vitro function studies indicate that this variant leads to impaired preproinsulin translocation across the endoplasmic reticulum membrane and accumulation of untranslocated preproinsulin in cytosol (Guo H et al 2014. PubMed ID: 24770419). However, another study showed that secretion of this mutant protein was not significantly different from wild type (Meur et al 2010. PubMed ID: 20007936). This variant is reported in 0.032% of alleles i n individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/11-2182185-C-T). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T;T;T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;.;.;T;T;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Benign
N;.;.;.;.;.
MutationTaster
Benign
N;N;N;N;N;N
PROVEAN
Benign
N;N;N;N;N;N
REVEL
Uncertain
Sift
Benign
T;T;T;T;T;T
Sift4G
Benign
T;T;T;T;.;T
Polyphen
B;B;B;B;.;B
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at